Source: Newsday

Hauppauge Digital: Hauppauge firm's losses double after its COVID-19 test is yanked by FDA

Chembio Diagnostics' CEO says the firm is seeking a reversal of the FDA's decision and developing a new test as well.Â

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

President & CEO

Kenneth H. Plotkin

CEO Approval Rating

70/100

Read more